Europe and the limits of international drug co-operation
Bibliographic Data
| ID | 5937389 |
|---|---|
| Authors | Elizabeth Joyce (Georgetown University, corresponding author) |
| Year | 1997 |
| Volume | 5 |
| Issue | 1 |
| Pages | 27-37 |
| Publication date | 1997-01-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | South African Journal of International Affairs (JOURNAL) |
| Journal identifiers | ISSN: 1022-0461 • E-ISSN: 1938-0275 |
| Publisher | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.1080/10220469709545208 |
| OpenAlex | W2084492993 |
| Language | EN |
There are wide differences in the approach of European states to the issue of drugs, with the liberal polices of the Netherlands at odds with neighbouring countries such as France and Germany. The lack of consensus, particularly in relation to ‘soft’ drugs such as cannabis, has been one factor that has acted as a limit on co‐operation among European states. Another is that the issue does not have the same dominant priority as it does for the United States. However, the process of European integration is putting pressure on those states which are members of the European Union to formulate a common approach on drugs and transnational crime, particularly with the steps being taken to remove the European Union's internal borders. The establishment of the European Monitoring Centre for Drugs and Drug Addiction illustrates another important trend in European drug policy, investment in data‐gathering on drug consumption
Business · Cannabis · Drug · European integration · European union · International trade · Odds · Political science · HIV, Drug Use, Sexual Risk · Medicine · Substance Abuse Treatment and Outcomes
| Highly cited | No |
|---|